Literature DB >> 17955435

Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin.

Dimitrios Paraskevis1, Emmanouil Magiorkinis, Gkikas Magiorkinis, Vana Sypsa, Vassilios Paparizos, Marios Lazanas, Panagiotis Gargalianos, Anastasia Antoniadou, Georgios Panos, Georgios Chrysos, Helen Sambatakou, Anastasia Karafoulidou, Athanasios Skoutelis, Theodoros Kordossis, Georgios Koratzanis, Maria Theodoridou, Georgios L Daikos, Georgios Nikolopoulos, Oliver G Pybus, Angelos Hatzakis.   

Abstract

BACKGROUND: In North America and Europe, human immunodeficiency virus (HIV)-1 infection has typically been dominated by subtype B transmission. More recently, however, non-B subtypes have been increasingly reported in Europe.
METHODS: We analyzed 1158 HIV-1-infected individuals in Greece by DNA sequencing and phylogenetic analyses of protease and partial reverse-transcriptase regions.
RESULTS: We found that the prevalence of non-B subtypes has increased over time and that this significant trend can be mainly attributed to subtype A, which eventually surpassed subtype B in prevalence in 2004 (42% and 33%, respectively). Multivariate analysis revealed that the year of HIV diagnosis was independently associated with subtype A infection (odds ratio for being infected with subtype A for a 10-year increase in the time period of diagnosis, 2.09 [95% confidence interval, 1.36-3.24]; P<.001). Phylogenetic analysis revealed that the subtype A epidemic in Greece is the result of a single founder event. The date of the most recent common ancestor of the subtype A in Greece was estimated to be 1977.9 (95% highest posterior density interval, 1973.7-1981.9).
CONCLUSIONS: Subtype A circulates among the long-term residents of Greece. This is in contrast to the situation in most European countries, in which infection with non-B genetic forms is associated either with being an immigrant or heterosexual or with intravenous drug use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955435     DOI: 10.1086/521677

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.

Authors:  Dimitrios Paraskevis; Georgios K Nikolopoulos; Vana Sypsa; Mina Psichogiou; Katerina Pantavou; Evangelia Kostaki; Timokratis Karamitros; Dimitra Paraskeva; John Schneider; Melpomeni Malliori; Samuel R Friedman; Don C Des Jarlais; Georgios L Daikos; Angelos Hatzakis
Journal:  Infect Genet Evol       Date:  2018-04-10       Impact factor: 3.342

2.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

3.  Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in Germany.

Authors:  Kirsten Hanke; Nuno Rodrigues Faria; Denise Kühnert; Kaveh Pouran Yousef; Andrea Hauser; Karolin Meixenberger; Alexandra Hofmann; Viviane Bremer; Barbara Bartmeyer; Oliver Pybus; Claudia Kücherer; Max von Kleist; Norbert Bannert
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

4.  Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men.

Authors:  Zoi-Anna Antoniadou; Ioanna Kousiappa; Lemonia Skoura; Dimitris Pilalas; Simeon Metallidis; Pavlos Nicolaidis; Nicolaos Malisiovas; Leondios G Kostrikis
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-18       Impact factor: 2.205

Review 5.  Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Authors:  Bluma Brenner; Mark A Wainberg; Michel Roger
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

6.  Using genomic signatures for HIV-1 sub-typing.

Authors:  Aridaman Pandit; Somdatta Sinha
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

7.  Algorithmic assessment of vaccine-induced selective pressure and its implications on future vaccine candidates.

Authors:  Mones S Abu-Asab; Majid Laassri; Hakima Amri
Journal:  Adv Bioinformatics       Date:  2010-02-01

8.  Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay.

Authors:  Gonzalo Bello; Paula C Aulicino; Dora Ruchansky; Monick L Guimarães; Cecilio Lopez-Galindez; Concha Casado; Hector Chiparelli; Carlos Rocco; Andrea Mangano; Luisa Sen; Mariza G Morgado
Journal:  Retrovirology       Date:  2010-03-22       Impact factor: 4.602

Review 9.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

10.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Authors:  Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis; Angelos Hatzakis; Annemarie Mj Wensing; David A van de Vijver; Jan Albert; Guiseppe Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Suzie Coughlan; Dominique Costagliola; Andrea De Luca; Carmen de Mendoza; Inge Derdelinckx; Zehava Grossman; Osama Hamouda; Im Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh Macrae; I Maljkovic-Berry; Laurence Meyer; Claus Nielsen; Eline Lm Op de Coul; Vidar Ormaasen; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika O Salminen; Jean-Claude Schmit; Rob Schuurman; Vincent Soriano; J Stanczak; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; M Violin; Sabine Yerly; Maurizio Zazzi; Charles A Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2009-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.